Belite Bio (BLTE) Other Non-Current Assets (2021 - 2026)

Belite Bio's Other Non-Current Assets history runs 6 years deep, the most recent figure standing at $289.4 million for Q1 2026.

• On a quarterly basis, Other Non-Current Assets rose 5789.44% year-over-year to $289.4 million in Q1 2026; TTM through Mar 2026 was $289.4 million, a 5789.44% increase from a year earlier, with the FY2025 full-year figure at $286.3 million, up 277845.63% from the prior year.
• Other Non-Current Assets improved to $289.4 million in Q1 2026 per BLTE's latest filing, from $286.3 million in the prior quarter.
• Across five years, Other Non-Current Assets topped out at $289.4 million in Q1 2026 and bottomed at $88000.0 in Q4 2022.
• The 5-year median for Other Non-Current Assets is $3.1 million (2023), against an average of $43.2 million.
• Biggest YoY gain for Other Non-Current Assets was 277845.63% in 2025; the steepest drop was 97.78% in 2025.
• Year by year, Other Non-Current Assets stood at $88000.0 in 2022, then increased by 18.18% to $104000.0 in 2023, then retreated by 0.96% to $103000.0 in 2024, then jumped by 277845.63% to $286.3 million in 2025, then advanced by 1.09% to $289.4 million in 2026.
• Per Business Quant, the three latest BLTE Other Non-Current Assets figures stand at $289.4 million (Q1 2026), $286.3 million (Q4 2025), and $101000.0 (Q3 2025).